Frontiers Drug Prevention and Control of Ventilator Associated Pneumonia Strategies to Prevent Ventilator Associated Pneumonia in Neonates Clinics in Perinatology Management of VAP Caused by Multidrug Resistant Pathogens Page 3 The challenge of ventilator associated pneumonia diagnosis in COVID 19 patients Critical Care Springer Nature Link The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000